United Therapeutics Corp (FRA:UTH)
€ 459 +13.1 (+2.94%) Market Cap: 20.06 Bil Enterprise Value: 17.35 Bil PE Ratio: 19.28 PB Ratio: 3.86 GF Score: 85/100

United Therapeutics Corp at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 01:30 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

UTHR.OQ - United Therapeutics Corp
United Therapeutics Corp at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Us this morning, as well as Harry Silver's, Investor Relations. James and Harry, thanks so much for joining us today. How are you both doing?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning.

Thank you, Lisa.

And really thanks RVC for hosting United Therapeutics this morning. Harry and I are really glad to be here. I'm going to turn it over to Harry to do an opening statement, looking statements before we start, if that's okay.

-----------------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot